10月21日，微灵医疗在深圳举办的脑机接口产业创新大会上发布全国首例闭锁综合征患者植入式脑机接口修复临床成果1。该患者因脑干出血导致全身瘫痪，植入脑机接口系统并完成康复训练后，左手运动功能评分从0分升至14分，已可独立完成抓握水瓶、抬起手腕等动作1。这一成果标志着国内植入式脑机接口技术在重症神经康复领域首次完成系统性临床验证1。
微灵医疗采用"修替一体"技术路线1，其研发的柔性薄膜皮层电极厚度仅为10微米1。同时，该企业研制的国内首款神经外科专用高通量数字脑电图机即将获批1。
2025年南山区医药产业增加值为53亿元，高端医疗器械产业增加值达93.38亿元1。南山区医药与医疗器械上市企业为15家，占全市的37.5%1。临床转化项目最高可获得500万元资助1。
On October 21, 2025, Shenzhen-based company Micro-Intelligence Medical announced the nation's first successful clinical case of implantable brain-computer interface restoration for a locked-in syndrome patient at the Brain-Computer Interface Industry Innovation Conference held in Shenzhen 1. The patient, who suffered complete paralysis following brainstem hemorrhage, received an implanted brain-computer interface system and underwent rehabilitation training, resulting in significant functional recovery 1. The patient's left hand motor function score on the Fugl-Meyer scale improved from 0 to 14 points, enabling independent completion of tasks such as grasping a water bottle and lifting the wrist 1. This breakthrough marks the first systematic clinical validation of domestic implantable brain-computer interface technology in severe neurological rehabilitation 1.
Micro-Intelligence Medical employed an integrated "repair and replacement" technological approach to achieve this result 1. The company's flexible thin-film cortical electrodes measure only 10 micrometers in thickness 1. The nation's first neurosurgery-specific high-throughput digital electroencephalography device is expected to receive regulatory approval 1.
评论
还没有评论，欢迎留下第一条。